#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Eosinophilic granulomatosis with polyangiitis Adult T-cell lymphoma/leukaemia refractory Philadelphia chromosome positive Nephrotic syndrome Hepatic cirrhosis Familial dilated cardiomyopathy Choroidal dystrophy Osteosarcoma Angiosarcoma non-metastatic Craniopharyngioma Myocarditis C3 glomerulopathy Polymyositis Cushing's syndrome Hypotransferrinaemia More trials…

    Learn about Rare Diseases

    Waldenstrom’s macroglobulinaemia refractory – Basic Information Gaucher’s disease type I – Basic Information Turner’s syndrome – Basic Information Antithrombin III deficiency – Trials in Disease Kearns-Sayre syndrome – Basic Information Alexander disease – Basic Information Hyperoxaluria – Trials in Disease Fragile X syndrome – Treatment Carcinoid syndrome – Trials in Disease Mucopolysaccharidosis – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Zelicapavir Remdesivir Olmesartan Medoxomil IADADEMSTAT Amitriptyline Hydrochloride Ripretinib Olea Europaea Pollen Extract ZIMISLECEL Fazirsiran Pemetrexed Tovorafenib Guanfacine Mannitol Rp-1664 Sulfate Ciprofloxacin Propranolol Hydrochloride Talquetamab Salmeterol SOFTISAN 378 ANX007 More therapies…

    Learn about Your Condition

    Oral neoplasm Strongyloidiasis Supraventricular tachycardia Post procedural swelling Hyperoxaluria Anorexia nervosa Ovarian cancer recurrent Osteomyelitis Malignant lymphoid neoplasm Immunodeficiency congenital Actinic cheilitis K-ras gene mutation Rosai-Dorfman syndrome Rhabdomyosarcoma recurrent Malignant neoplasm of choroid More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Adrenocortical carcinoma

  • Study on the Effectiveness of Adding Progesterone to Chemotherapy with Etoposide, Doxorubicin, Cisplatin, and Mitotane for Advanced Adrenocortical Carcinoma Patients

    Recruiting

    2 1 1
    Investigated Diseases:
    • Adrenocortical carcinoma
    Investigated Drugs:
    • MEGESTROL ACETATE
    • Mitotane
    • Cisplatin
    Italy

  • Study on Mitotane Alone or with Cisplatin and Etoposide for Patients with High-Risk Adrenocortical Carcinoma After Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Adrenocortical carcinoma
    Investigated Drugs:
    • Mitotane
    • Cisplatin
    • Etoposide
    France Germany Sweden

  • Cisplatin with drug combination in hyperthermic intraperitoneal chemotherapy for stage II‑III adrenocortical carcinoma patients

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Adrenocortical carcinoma
    Investigated Drugs:
    • Sodium Nitrite
    • Sodium Thiosulfate
    • Cisplatin
    Italy

  • Phase II study of intratumoral GETACATETIDE in patients with locally advanced or metastatic adrenocortical carcinoma

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Adrenocortical carcinoma
    France Germany Norway Spain

  • Study on Cemiplimab and Mitotane for Patients with Advanced Adrenocortical Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Adrenocortical carcinoma
    Investigated Drugs:
    • Mitotane
    • Cemiplimab
    Italy

  • Study of Pembrolizumab for Patients with Advanced Adrenocortical Carcinoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Adrenocortical carcinoma
    Investigated Drugs:
    • Pembrolizumab
    Poland

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!